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Abstract: Most current hypotheses
regarding the pathophysiologic mechanisms
of pregnancy-induced hypertention point to
early placental abnormalities. Therefore, we
attempted to determine whether serum
human chorionic gonadotropin (hCG) levels
reflect a different trophoblastic secretory
response of preeclampsia. Thirteen pregnant
women with severe preeclampsia were
matched with twenty-one normotensive

pregnant women with singleton pregnancies
in the third trimester. Serum b-hCG levels
were found to be significantly higher in
severe preeclampsia, compared with controls
(p<0.05). This indicates that an abnormal
secretory function of the placenta exists in
patients with severe preeclampsia.
Key Words: Preeclampsia, human chorionic
gonadotropin.

Introduction

Materials and Methods

Pregnancy associated hypertensive disorders and
intrauterine growth restriction are common
complications responsible for fetal, neonatal, and
maternal morbidity (1, 2). Most current hypotheses
regarding the pathophysiologic mechanisms of
pregnancy-induced hypertention point to early placental
abnormalities. Human placenta synthesizes steroid,
protein, and glycoprotein hormones throughout gestation
(3). The production of hCG by the placenta in early
pregnancy is critical for implantation and maintanance of
the blastocyst. Since it is postulated that preeclampsia is
likely a trophoblastic disorder (4), it may be essential for
understanding of this disease, to investigate the
pathologic and secretory reaction of the placenta. Twin
pregnancies (5) and molar pregnancies (6) produce
higher levels of hCG and they are associated with a
higher incidence of preeclampsia than uncomplicated
singleton pregnacies. An association was reported
between preeclampsia and elevated third trimester hCG
levels (7), whereas early experience with second
trimester levels suggests a link between increased hCG
and other adverse pregnancy outcomes (8, 9).
Considerable evidence suggests an association between
serum hCG levels and preclampsia (9-14). We therefore
investigated whether the level of serum b-hCG does
correlate with the severity of preeclampsia and might
reflect a different trophoblastic secretory response of this
disease.

Thirteen women with severe preeclampsia and
twenty-one normotensive, healthy pregnant women with
singleton pregnancies in the third trimester were
matched. None of them had a history of chronic
hypertention. This investigation was designed as a
prospective study. Subjects were mathced for gestational
and maternal age. The criteria for severe preeclampsia
were (1) systolic blood pressure ≥160 mm Hg or
diastolic ≥110 mm Hg and (2) proteinuria >5 gm in 24
hours. In addition, any patient with oliguria (400 ml in
24 hours), cerebral or visual disturbances, epigastric
pain, pulmonary edema, or abnormal platelet count and
liver function profile was included in severe preeclampsia.
The venous blood samples were obtained from the
subjects and centrifugated at 2000g for 10 minutes at
4°C. Sera were collected and stored at - 20°C until
analysis. Serum levels of β-hCG (Immulite β-hCG, DPC®
Los Angeles, CA) were measured by chemilluminecence.
Total blood and urine biochemistries were examined.
Student’s t test and the Mann Whitney U test were used
for statistical analysis. For statistical significance, a p
value was set at < 0.05.
Results
Clinical data and serum β-hCG levels are shown in
Table 1. and are expressed as mean±SEM. There was no
difference between the two groups in terms of mean
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Severe preeclampsia (n=13)

Controls (n=21)

Maternal Age (yr)

20.7±1.1

21.3 ±1.6

Gestational age (wk)

33.9±2.0

35.1±2.2

Serum uric acid (mg/dl)

6.2±2.1*

Serum creatinin (mg/dl)

Table 1.

Subject data and serum βhCG
levels
in
severe
preeclampsia and controls.

3.5±0.8

0.82±0.1

0.79±0.1

MAP (mm Hg)

121.8±4.7*

73.4±5.8

Serum β-hCG (mIU/ml)

33960±4048.74*

18634±1618.47

MAP: Mean arterial pressure, * p < 0.05.

age, gestational age or serum creatinine levels (20.7±1.1,
33.9± 2.0, 0.82± 0.1 vs 21.3± 1.6, 35.1± 2.2, 0.79±
0.1 respectively) (p > 0.05). In the preeclamptic group,
mean arterial tensions, serum uric acid and β-hCG levels
were significantly higher than in the controls (121.8±
4.7, 6.2± 2.1, 33960± 4.48.74 vs 73.4± 5.8, 3.5± 0.8,
18634± 1618.47 respectively) (p < 0.05).
Discussion
In this study, we found that serum β-hCG levels were
significantly elevated in severe preeclampsia, compared
with the controls. This finding indicates that an abnormal
secretory function exists in patients with severe
preeclampsia.
In preeclampsia, placental pathologic examination
reveals focal cellular necrosis in the syncytiotrophoblast
and increased mitotic activity with cellular proliferation in
the cytotrophoblast (15). In addition, the proliferating
cytotrophoblast in severe preeclampsia is rapidly
transformed into syncytiotrophoblast within 72 hours
(16). The normal placenta differentiates during
pregnancy with the cytotrophoblast dominant in early
gestation and the syncytotrophoblast dominant in late
pregnancy (17). It is well known that the cytotrophoblast
is an undifferentiated stem cell and the
syncytotrophoblast is a differentiated trophoblast
transformed from the cytotrophoblast (18). Although the
mechanism of regulation of gestational hCG remains
largely unknown, it is generally accepted that hCG, are
only secreted by syncytotrophoblasts (19). Recently
Maruo et al. (20) showed that β-hCG could be detected in
the cytotrophoblast in very early pregnancy. In a clinical
study, hCG levels were assayed in 62 patients with
toxemia; 28 of the 62 patients had serum hCG levels
above the normal range, indicating that early placental
vascular damage leading to decreased oxygen supply
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might result in increased hCG production by hyperplastic
cytotrophoblastic cells (21). Also, hCG production has
been shown to increase when normal placental villi in
organ cultures were maintained under hypoxic conditions
(22). Typically, the placenta is the affected tissue in
pregnancies complicated by hypertention (23).
As it is known that total hCG and β-hCG are
predominantly produced by syncytiotrophoblast and they
can be also detected in the differentiating cytotrophoblast
(20), many authors studied serum levels of hCG and βhCG in preeclampsia to define an abnormal placental
secretory function or to predict the development of
preeclampsia before this disease is manifest. In 1934,
Smith et al. (10), talked about increasing hCG Levels in
severe preeclampsia for the first time. Taylor et al. (24)
in 1939 and Loraine et al. (25) in 1950, reported similar
results. However, contrary results have been reported in
1968 by Teoh and Sivasamboo (26). But recently, an
association was found between elevated serum β-hCG
levels and preclampsia in the third trimester (7), whereas
an elevation in serum β-hCG levels in the second trimester
has been linked with the devolopment of preeclamsia
(11, 13, 14). A relationship was also reported between
adverse pregnancy outcome and elevated second
trimester serum β-hCG levels (8, 9, 27).
In conclusion, we found a strict relationship between
severe preeclampsia and elevated serum β-hCG levels,
indicating that there should be an abnormal placental
secretory function in patients with severe preeclampsia.
The use of these findings to prevent adverse pregnancy
outcome should be further investigated.
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